Solvo Biotechnology Competitors and Similar CompaniesClear all

Solvo Biotechnology's competitors and similar companies include LifeNet Health, EastWest Bioscience, Cellbox Solutions and Glenmark Pharmaceuticals.

	Solvo Biotechnology SOLVO Biotechnology is a company that provides drug transporter products and services.	LifeNet Health LifeNet Health is a provider of transplant solutions.	EastWest Bioscience EastWest Bioscience company is engaged in a multitude of brands in retail, manufacturing, supply chain, storage & distribution	Cellbox Solutions Cellbox Solutions is a company providing logistic solutions for the biomed industry.	Glenmark Pharmaceuticals Glenmark Pharmaceuticals is a pharmaceutical company that develops and markets branded and generic formulations.
Founding Date	Founding Date 1999	Founding Date 1982	Founding Date 2016	Founding Date 2016	Founding Date 1977
Type	Type Subsidiary	Type Private	Type Public	Type Private	Type Public
Tags	Tags Healthcare biotech transportation	Tags Healthcare biotech medical devices	Tags Healthcare biotech real estate transportation	Tags Healthcare biotech logistics transportation	Tags Healthcare biotech pharma
Locations	Locations Budapest, HU HQ Szeged, HU Boston, US Issaquah, US San Francisco, US	Locations Virginia Beach, US HQ Wien, AT Billings, US Durham, US Indianapolis, US Jacksonville, US Missoula, US see more	Locations HQ	Locations Kiel, DE HQ	Locations Mumbai, IN HQ Mumbai, IN
Employees	Employees 8719% decrease	Employees 1,3132% increase	Employees N/A	Employees 20	Employees 14,989
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) $598.6m (FY, 2024)	Revenue (est.) $1.1m (FY, 2021)	Revenue (est.) N/A	Revenue (est.) ₹131.5b (FY, 2025)
Cost of goods	Cost of goods N/A	Cost of goods N/A	Cost of goods $480k (FY, 2021)	Cost of goods N/A	Cost of goods ₹46.7b (FY, 2025)
Gross profit	Gross profit N/A	Gross profit N/A	Gross profit $577k (FY, 2021)	Gross profit N/A	Gross profit ₹87b (FY, 2025)
Net income	Net income N/A	Net income $18m (FY, 2024)	Net income ($1.6m) (FY, 2021)	Net income N/A	Net income ₹10.5b (FY, 2025)